Infertility
Infertility refers to a disease in which a woman of childbearing age has been living with her husband for more than two years after marriage or the last pregnancy, and the man has normal reproductive function and has not conceived without contraception. Those who have never conceived in the past two years after marriage are called primary infertility; those who have had a childbirth or miscarriage and have been infertile for more than two consecutive years are called secondary infertility. Absolute infertility refers to a clinical sign of infertility caused by severe congenital or acquired anatomical abnormalities or physiological defects in either spouse, which cannot be successfully corrected no matter what method is used for treatment, such as congenital absence of the uterus. Relative infertility refers to a certain cause of difficulty in conceiving that reduces fertility, causing the patient to be unable to conceive temporarily, but can still conceive through treatment, such as uterine hypoplasia. The incidence of infertility accounts for about 8% to 17% of women of childbearing age, with an average of about 10%. The increasing trend of the incidence of infertility may be related to late marriage and childbearing, artificial abortion, sexually transmitted diseases, etc. Common infertility includes ovarian infertility, vulvovaginal infertility, cervical infertility, uterine infertility, fallopian tube infertility, chromosomal abnormality infertility, and immune infertility.
Related Drugs
Urinary gonadotropin for injection
Indication: Used in combination with chorionic gonadotropin, it is used for primary or secondary amenorrhea caused by insufficient gonadotropin secretion, infertility caused by anovulation, etc.
Manufacturer:
Ningbo Renjian Pharmaceutical Group Co., Ltd.
progesterone capsules
Indication: Threatened abortion and habitual abortion, premenstrual tension syndrome, anovulatory functional uterine bleeding and anovulatory amenorrhea, used in combination with estrogen to treat menopausal syndrome.
Manufacturer:
Zhejiang Aisheng Pharmaceutical Co., Ltd.
Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:
Sancai Shiqi Pharmaceutical Co., Ltd.
Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:
Sancai Shiqi Pharmaceutical Co., Ltd.
BROMOCRIPTINE MESYLATE- bromocriptine mesylate_tablet
Indication: Hyperprolactinemia-Associated Dysfunctions hyperprolactinemia amenorrhea galactorrhea, infertility or hypogonadism prolactin-secreting adenomas, Reduction tumor size Acromegaly Parkinson’s Disease
Manufacturer:
Bionpharma Inc.
PREGNYL- choriogonadotropin alfa
Indication: HCG HAS NOT BEEN DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF OBESITY. THERE IS NO SUBSTANTIAL EVIDENCE THAT IT INCREASES WEIGHT LOSS BEYOND THAT RESULTING FROM CALORIC RESTRICTION, THAT IT CAUSES A MORE ATTRACTIVE OR “NORMAL” DISTRIBUTION OF FAT, OR THAT IT DECREASES THE HUNGER AND DISCOMFORT ASSOCIATED WITH CALORIE-RESTRICTED DIETS. Prepubertal cryptorchidism not due to anatomical obstruction. In general, hCG is thought to induce testicular descent in situations when descent would have occurred at puberty. hCG thus may help predict whether or not orchiopexy will be needed in the future. Although, in some cases, descent following hCG administration is permanent, in most cases, the response is temporary. Therapy is usually instituted in children between the ages of 4 and 9. Selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males. Induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately treated with human gonadotropins.
Manufacturer:
Merck Sharp & Dohme LLC
BROMOCRIPTINE MESYLATE- bromocriptine mesylate_tablet
Indication: Hyperprolactinemia-Associated Dysfunctions hyperprolactinemia amenorrhea galactorrhea, infertility or hypogonadism prolactin-secreting adenomas, Reduction tumor size Acromegaly Parkinson’s Disease
Manufacturer:
Bionpharma Inc.
PREGNYL- choriogonadotropin alfa
Indication: HCG HAS NOT BEEN DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF OBESITY. THERE IS NO SUBSTANTIAL EVIDENCE THAT IT INCREASES WEIGHT LOSS BEYOND THAT RESULTING FROM CALORIC RESTRICTION, THAT IT CAUSES A MORE ATTRACTIVE OR “NORMAL” DISTRIBUTION OF FAT, OR THAT IT DECREASES THE HUNGER AND DISCOMFORT ASSOCIATED WITH CALORIE-RESTRICTED DIETS. Prepubertal cryptorchidism not due to anatomical obstruction. In general, hCG is thought to induce testicular descent in situations when descent would have occurred at puberty. hCG thus may help predict whether or not orchiopexy will be needed in the future. Although, in some cases, descent following hCG administration is permanent, in most cases, the response is temporary. Therapy is usually instituted in children between the ages of 4 and 9. Selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males. Induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately treated with human gonadotropins.
Manufacturer:
A-S Medication Solutions